Exposure-Response Relationship

Exposure-Response Relationship describes the quantitative link between drug exposure levels, typically measured as concentration or area under the curve, and resulting pharmacological or clinical effects. This relationship supports rational dose selection by identifying exposure ranges that produce optimal efficacy while minimising toxicity. Exposure-response modelling integrates pharmacokinetic and pharmacodynamic data to predict outcomes under different dosing regimens.

The pharmaceutical industry uses exposure-response analysis extensively in model-informed drug development to guide dose optimisation, evaluate variability sources, and support regulatory dosing recommendations. Clinical pharmacology programmes assess whether higher exposure improves efficacy or increases adverse events, informing dose adjustments for special populations. Regulatory submissions include exposure-response evidence supporting label dosing, titration guidance, and therapeutic monitoring recommendations. As precision medicine advances, exposure-response relationships increasingly incorporate biomarkers and genetic factors to individualise therapy. This quantitative framework remains central to achieving safe and effective dosing strategies across diverse patient populations.